dc.contributor
Institut Català de la Salut
dc.contributor
[Pinteac R, Montalban X, Comabella M] Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) - ISCIII, Madrid, Spain. [Soriano J] Departament de Física de la Matèria Condensada, Facultat de Física, Universitat de Barcelona, Barcelona, Spain. Universitat de Barcelona Institute of Complex Systems (UBICS), Universitat de Barcelona, Barcelona, Spain. [Matute-Blanch C, Malhotra S, Eixarch H, López Comellas G] Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Lizcano JM] Grup de Recerca de Proteïnes Kinases i Càncer, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Bioquímica i Biologia Molecular and Institut de Neurociències, Facultat de Medicina, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Duarri A] Grup de Recerca d’Oftalmologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Pinteac, Rucsanda
dc.contributor.author
Soriano Fradera, Jordi
dc.contributor.author
Matute Blanch, Clara
dc.contributor.author
lizcano, jose m
dc.contributor.author
López Comellas, Gloria
dc.contributor.author
Duarri, Anna
dc.contributor.author
Malhotra Sareen, Sunny
dc.contributor.author
Eixarch, Herena
dc.contributor.author
Comabella Lopez, Manuel
dc.contributor.author
Montalban, Xavier
dc.date.issued
2025-02-05T13:44:15Z
dc.date.issued
2025-02-05T13:44:15Z
dc.identifier
Pinteac R, Soriano J, Matute-Blanch C, Lizcano JM, Duarri A, Malhotra S, et al. Chitinase 3-like 1 is neurotoxic in multiple sclerosis patient-derived cortical neurons. Clin Transl Med. 2024 Dec;14(12):e70125.
dc.identifier
https://hdl.handle.net/11351/12556
dc.identifier
10.1002/ctm2.70125
dc.identifier
001374950800001
dc.description.abstract
Quitinasa; Esclerosis múltiple; Efectos neurotóxicos
dc.description.abstract
Quitinasa; Esclerosi múltiple; Efectes neurotòxics
dc.description.abstract
Chitinase; Multiple sclerosis; Neurotoxic effects
dc.format
application/pdf
dc.relation
Clinical and Translational Medicine;14(12)
dc.relation
https://doi.org/10.1002/ctm2.70125
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Marcadors bioquímics
dc.subject
Esclerosi múltiple - Tractament
dc.subject
DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis
dc.subject
Other subheadings::Other subheadings::Other subheadings::/drug therapy
dc.subject
CHEMICALS AND DRUGS::Enzymes and Coenzymes::Enzymes::Hydrolases::Glycoside Hydrolases::Chitinases
dc.subject
ANATOMY::Nervous System::Neurons
dc.subject
CHEMICALS AND DRUGS::Biological Factors::Biomarkers
dc.subject
ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple
dc.subject
Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::enzimas y coenzimas::enzimas::hidrolasas::glicósido hidrolasas::quitinasas
dc.subject
ANATOMÍA::sistema nervioso::neuronas
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores
dc.title
Chitinase 3-like 1 is neurotoxic in multiple sclerosis patient-derived cortical neurons
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
